SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ARB IOT Group Ltd. is a holding company that engages in the provision of solutions for the integration of IoT systems and devices. It operates through the Internet of Things and Investment Holding and Others segments. The company was founded on March 1, 2022 and is headquartered in Singapore.

ARB IOT Group Ltd

ARBB is trending due to renewed interest in its low float and past volatility, with traders actively discussing a potential short squeeze. Community members are focused on accumulation patterns and key breakout levels, anticipating a rapid price surge. The stock's potential connection to AI and IoT sectors may also be contributing to the increased attention.

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

Anavex Life Sciences Corporation

Anavex Life Sciences Corp

AVXL is trending due to anticipation surrounding the EMA's decision on Blarcamesine, a potential Alzheimer's treatment, with the community closely monitoring the EMA website for updates. Discussions revolve around the timing of the announcement, potential approval scenarios, and the impact on short positions. Community members express strong conviction in the science behind Blarcamesine and its potential to shift the treatment landscape for Alzheimer's.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is experiencing volatility, with some traders pointing to recent price drops as a sign of an impending bear market. Community discussions revolve around key support levels and whether the current downturn presents a buying opportunity or a reason to sell. The broader market context includes uncertainty around Federal Reserve rate cuts and comparisons to previous market cycles.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending downwards as the broader tech sector experiences a selloff and investors react to news including a Powerwall recall. Community discussions revolve around potential bottom levels, technical analysis predicting further declines, and debates about the company's valuation and future prospects. Some traders are anticipating a bounce, while others remain bearish, pointing to concerns about competition and execution.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Strategy is trending downwards, with community members expressing concerns about its correlation to Bitcoin's recent struggles and potential margin calls. Discussions revolve around Saylor's strategy, dilution, and the overall financial health of the company, with some speculating about a significant drop. The sentiment is largely bearish as traders assess whether the stock is oversold or headed for further decline.

Cidara Therapeutics, Inc. engages in developing targeted immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases. Its platform, Cloudbreak, enables development of novel drug-Fc conjugates (DFCs) that inhibit specific disease targets while simultaneously engaging the immune system. The company was founded by Kevin M. Forrest, Kevin J. Judice, and H. Shaw Warren in December 2012 and is headquartered in San Diego, CA.

Cidara Therapeutics Inc

Cidara Therapeutics is trending following news that Merck is nearing a deal to acquire the company, potentially paying a significant premium. The community is discussing the potential acquisition price, possible CVR, and what this means for other companies in the sector. Some investors are expressing excitement about a potential payday after holding the stock for years.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

APLD is trending due to investor concerns surrounding a proposed $2.35B junk bond offering and its reliance on CoreWeave as a primary tenant; the community is debating whether this signals financial risk or a buying opportunity as institutional investors increase their positions. Some investors believe the AI data center sector is experiencing a broader market correction. Bulls emphasize the company's signed contracts, revenue outlook, and power infrastructure, viewing the pullback as a macro-driven opportunity.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending amid discussions about its debt, reliance on Nvidia, and a recent pullback despite strong revenue growth and a massive backlog, with some fearing an AI bubble while others see a buying opportunity. Community members are debating whether the stock is oversold and if institutional selling indicates further declines or a potential rebound. Applied Digital's bond offering is also in focus due to its dependence on CoreWeave as a major tenant, adding to investor concerns.

Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. The MedSurg and Neurotechnology segment includes surgical equipment and navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment, intensive care disposable products, clinical communication, workflow solutions, products for the treatment of acute ischemic and hemorrhagic stroke, traditional brain, and open skull based surgical procedures, orthobiologic, and biosurgery. The Orthopaedics and Spine segment focuses on implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar, and interbody systems used in spinal injury, deformity, and degenerative therapies. The company was founded by Homer H. Stryker in 1941 and is headquartered in Portage, MI.

Stryker Corp.

Stryker is trending as analysts adjust price targets following recent earnings, with community members weighing in on future growth potential. Discussions focus on the company's innovation in medical devices and leadership in orthopedic and surgical technologies. The community is closely monitoring Stryker's performance relative to its peers in the medical technology sector.

Lynas Rare Earths Ltd. engages in the production of rare earth minerals. It focuses on the exploration, development, mining, and processing of rare earth deposits. The company was founded by Nicholas Anthony Curtis on May 23, 1983 and is headquartered in Perth, Australia.

Lynas Rare Earths Limited

LYSCF is trending as investors weigh its strategic importance amid increasing demand for rare earths and geopolitical tensions between the U.S. and China. Community discussions focus on Lynas' increased output, its role as a non-Chinese supplier, and potential benefits from U.S.-Australia deals, along with the company's expansion plans and profitability compared to peers. Some are concerned with supply chain disruptions and export control, while others see it as an alternative way to break China's grip on the rare earth elements supply chain.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ENB
Share Price: $46.91

Contract Selected: Apr 17, 2026 $50 Calls

Buy Zone: $0.77 – $0.95
Target Zone: $1.32 – $1.62
Potential Upside: 64% ROI

Time to Expiration: 169 Days | Updates via https://fxcapta.com/stockinfo/

Jeremy Warren

Every trade is a home run. Over 96% win rate on all trades for the past two years, over 200 total trades. Disclaimer: The information provided on this website is for educational and informational purposes only and does not constitute financial advice. Trading involves risk, and past performance is not indicative of future results.

Fxcapta

fxcapta.com

StockTwits Web

Enbridge Inc


Share Price: $46.91

Contract Selected: Apr 17, 2026 $50 Calls

Buy Zone: $0.77 – $0.95
Target Zone: $1.32 – $1.62
Potential Upside: 64% ROI

Time to Expiration: 169 Days | Updates via 